
New drug has potential to turn COVID-19 virus against itself Scripps Research team showed that a variation of an already FDA-approved therapeutic for neurological disease can block COVID-19 infection in animals.
September 29, 2022
LA JOLLA, CA A new drug designed by scientists at Scripps Research can turn the COVID-19 virus into a harbinger of its own doom.
The drug, NMT5, described in Nature Chemical Biology on September 29, 2022, coats SARS-CoV-2 with chemicals that can temporarily alter the human ACE2 receptor the molecule the virus normally latches onto to infect cells. That means that when the virus is near, its path into human cells via the ACE2 receptor is blocked; in the absence of the virus, however, ACE2 can function as usual.
What's so neat about this drug is that we're actually turning the virus against itself, says senior author Stuart Lipton, MD, PhD, the Step Family Endowed Chair and Scripps Research professor. We're arming it with little molecular warheads that end up preventing it from infecting our cells; it's our revenge on the virus.
Before the COVID-19 pandemic, Lipton and his colleagues had long been studying variations of the drug memantine, which Lipton developed and patented in the 1990s for treating neurological diseases like Alzheimer's. While memantine originated from an anti-influenza drug used in the 1960s, clinicians began investigating it for additional diseases after they noticed a woman with Parkinson's symptoms improved when she took the drug for the flu.
My team had made these antiviral drugs better for the brain, and when COVID-19 emerged, we wondered whether we had also, in the process, made any of them better antivirals, says Lipton.
Lipton and his team tested a library of compounds similar to memantine in overall structure but covered with additional pharmacological warheads. They pinpointed the drug candidate designated NMT5 as having two key properties: It could recognize and attach to a pore on the surface of SARS-CoV-2, and it could chemically modify human ACE2 using a fragment of nitroglycerin as the warhead. The group realized this could turn the virus into a delivery vehicle for its own demise.
In the new paper, Lipton's group characterized and tested NMT5 in isolated cells as well as animals. They showed how NMT5 attaches tightly to SARS-CoV-2 viral particles as the viruses move through the body. Then, they revealed the details of how the drug adds a chemical (similar to nitroglycerin) to certain molecules if it gets close enough. When the virus gets near ACE2 to infect a cell, that translates into NMT5 adding a nitro group to the receptor. When ACE2 is modified in this way, its structure temporarily shifts for about 12 hours so that the SARS-CoV-2 virus can no longer bind to it to cause infection.
What's really beautiful is that this only knocks down availability of ACE2 locally when the virus is coming at it, says Lipton. It doesn't knock down all the function of ACE2 elsewhere in the body, allowing for normal function of this protein.
In cell culture experiments testing how well the Omicron variant of SARS-CoV-2 can attach to human ACE2 receptors, the drug prevented 95% of viral binding. In hamsters with COVID-19, NMT5 decreased virus levels by 100-fold, eliminated blood vessel damage in the animals' lungs, and ameliorated inflammation. The drug also showed effectiveness against nearly a dozen other variants of COVID-19, including alpha, beta, gamma and delta strains.
Most anti-viral drugs work by directly blocking part of a virus which can pressure the virus to evolve resistance to the drug. Since NMT5 is only using the virus as a carrier, the researchers think the drug is likely to be effective against many other variants of SARS-CoV-2.
We expect this compound would continue to be effective even as new variants emerge, because it doesn't rely on attacking parts of the virus that commonly mutate, says Chang-ki Oh, a senior staff scientist and first author of the new paper.
Though they have only studied the compound in animal models, the team is now making a version of the drug to evaluate for human use, while carrying out additional safety and effectiveness trials in animals. This work is being sponsored by the Scripps Center Grant for Antiviral Medicines & Pandemic Preparedness (CAMPP AViDD) from the National Institutes of Health (U19 AI171443).
These exciting findings suggest a new avenue for drug development that requires drug combinations for effective pandemic preparedness, says co-author Arnab Chatterjee, PhD.
In addition to Lipton, Oh and Chatterjee, authors of the new paper are Tomohiro Nakamura, Nathan Beutler, Xu Zhang, Juan Pi a-Crespo, Maria Talantova, Swagata Ghatak, Dorit Trudler, Lauren N. Carnevale, Scott R. McKercher, Malina A. Bakowski, Jolene K. Diedrich, Amanda J. Roberts, Ashley K. Woods, Victor Chi, Anil K. Gupta, Namir Shaabani, Hejun Liu, Ian A. Wilson, Dennis R. Burton, John R. Yates III and Thomas F. Rogers of Scripps Research; Mia A. Rosenfeld, Fiona L. Kearns, Lorenzo Casalino and Rommie E. Amaro of UCSD; and Cyrus Becker of EuMentis Therapeutics, Inc.
This work was supported in part by grants from the National Institutes of Health (RF1 AG057409, R01 AG056259, R01 DA048882, R35 AG071734 and DP1 DA041722, R01 AG061845, R61 NS122098, RF1 NS123298, UM1 AI144462, P41 GM103533, HOPE T32 Training Grant T32AI007384), the California Institute for Regenerative Medicine (DISC2 COVID19-11811), COVID-19 awards from Fast Grants, and the Bill & Melinda Gates Foundation (OPP1107194, INV-004923).
Lipton is an inventor of patents for the use of memantine and related compounds for neurodegenerative and neurodevelopmental disorders. He is also an inventor of composition of matter patents and use patents for aminoadamantane nitrate compounds like NMT
North America Stories
20/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
20/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
20/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
20/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
20/11/2026
Beam Dynamics has introduced new Model Context Protocol (MCP) support, expanding how customers can work with the live operational data held in Beam. The new cap...
20/11/2026
Re:Vision Effects Cyber Week Sale Nov 24 to Nov 30
Pierre Jasmin November 19, 2026
0 Comments
Long time friends of the COW are up with a big sale!
Us...
20/11/2026
Avid is offering up to 33% off annual subscriptions!
Brie Clayton November 19, 2026
0 Comments
Hero image courtesy Deposit Photos
Pro Tools
Pro To...
19/11/2026
With a sports-bar vibe and all the teams onsite in a huge atrium in Ballpark Vil...
19/11/2026
The senior from Phoenix and England is balancing life as a Division I tennis player with a growing career behind the microphone
The future of live sports produ...
19/11/2026
RED Digital Cinema and Colorfront have partnered to integrate native Colorfront color management into RED Connect, letting productions apply Colorfront's co...
19/11/2026
SMPTE has published an engineering report summarizing an industry survey by its Study Group on Content Provenance and Authenticity in Media. The findings point ...
19/11/2026
CTech and Skyline Communications have announced a partnership to deliver integra...
19/11/2026
Euskal Irrati Telebista (EITB), the Basque Country's public media group, has completed Phase 1 of a five-studio renewal with the commissioning of a Lawo IP ...
19/11/2026
The Esports Foundation (EF) has announced an expanded Road to ENC 2027 for the E...
19/11/2026
All Women's Sports Network (AWSN) held its first awards show, VEON: Women W...
19/11/2026
Gracenote, the content intelligence business unit of Nielsen, has extended its relationship with DIRECTV. Gracenote will continue to supply visual imagery and p...
19/11/2026
The Audio Engineering Society (AES) Technical Committee on Broadcast and Online ...
19/11/2026
NDI has released NDI 6.4, which adds Recording and Playback APIs, support for HEVC 4:4:4 and a configurable receiver buffer for Wi-Fi. The update also includes ...
19/11/2026
Lemonlight, the video production company behind more than 50,000 brand videos, has announced Hero, an AI production operating system, along with a new AI agent ...
19/11/2026
In a first-of-its-kind deployment at XFINITY Center, the digital signage/display...
19/11/2026
For the first time on a US streaming service, real-time player identification, contextual stats, and visual insights appear right in the live stream, available ...
19/11/2026
His career runs from the 2-in. videotape era to Canada's first HD and UHD live-production facilities...
19/11/2026
The popular sports-graphics event features a new Chairperson and new venue...
19/11/2026
Beth de Ara jo, Gemma Chan, Channing Tatum and Mason Reeves attend the premiere of Josephine at Eccles Theatre on January 23, 2026, in Park City, UT. (Photo b...
19/11/2026
On October 8, 2026, Nielsen employees came together around the world to celebrate our fourteenth company-wide day of service, Nielsen Global Impact Day (NGID). ...
19/11/2026
Integrating Gracenote's content intelligence with Nexxen's unique CTV supply allows advertisers to more closely align campaigns with audience viewing ha...
19/11/2026
Enhancement Mirrors Local TV's Recent Move to 1-Minute Qualifier (1MQ)
Upda...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , er...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
19/11/2026
As Founder and Creative Director of Future Phonic Studios, the Netherlands' first Dolby Atmos music studio, Richard Burki has spent more than a decade pushi...
19/11/2026
Boris FX Black Friday Sale - 25% Off Everything
Brie Clayton November 19, 2026
0 Comments
Check out the Boris FX Black Friday sale on Monday, November...
19/11/2026
Virtual Production Finds Its Middle Ground with Blackmagic Design
Brie Clayton November 19, 2026
0 Comments
How Neon Vision is using PYXIS 12K and Ult...
19/11/2026
FL Studio Announces Black Friday Discounts of Up to 50% Across Its Software Line...
19/11/2026
TBS Drama Series Tagusari Brothers Uses DaVinci Resolve Studio
Brie Clayton November 19, 2026
0 Comments
TBS ACT streamlines post production for broad...
19/11/2026
Beeble launches SwitchX 3.0 with dynamic environments and greater creative contr...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , er...
19/11/2026
Five-year deployment has automated APL's media supply chain from fixture to archive, managing over 200,000 assets
Blue Lucy, the workflow orchestration and...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
19/11/2026
iStreamU LLC, a rapidly growing production and systems integration company founded by longtime Producer/Director Ivan Gonzalez, has standardized its audio workf...
19/11/2026
LA JOLLA, CA-Clarivate, a global information and analytics company, named seven ...
19/11/2026
NVIDIA and Microsoft are extending their full-stack collaboration to help organizations build, customize and deploy intelligent applications - from next-generat...
19/11/2026
GeForce NOW is kicking off Black Friday with more reasons to make time for gaming. Six-month memberships are back for a limited time. Save 30% on the first six-...
18/11/2026
Held in New York City, the event explored the latest technologies and trends shaping the future of live-sports transmission and distribution...